-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation